A. Lévy

1.1k total citations
28 papers, 799 citations indexed

About

A. Lévy is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, A. Lévy has authored 28 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Pharmacology and 5 papers in Cognitive Neuroscience. Recurrent topics in A. Lévy's work include Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Pesticide Exposure and Toxicity (5 papers). A. Lévy is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Pesticide Exposure and Toxicity (5 papers). A. Lévy collaborates with scholars based in Israel, United States and Spain. A. Lévy's co-authors include S. Spector, Shlomit Dachir, Tamar Kadar, Rachel Brandeis, Alan R. Gintzler, Kenji Kawashima, Barbara Shukitt‐Hale, Abraham Fisher, Michal Sapir and Georgia Roberts and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

A. Lévy

28 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lévy Israel 16 269 224 123 122 116 28 799
Perrie M. Adams United States 23 410 1.5× 433 1.9× 121 1.0× 239 2.0× 97 0.8× 55 1.4k
S.K. Kulkarni India 20 357 1.3× 237 1.1× 53 0.4× 124 1.0× 103 0.9× 46 1.1k
Dorothy E. Woolley United States 19 401 1.5× 199 0.9× 107 0.9× 81 0.7× 51 0.4× 60 1.2k
Roberta Monterazzo Cysneiros Brazil 20 265 1.0× 156 0.7× 134 1.1× 172 1.4× 59 0.5× 68 971
Mario Eduardo Flores-Soto Mexico 19 318 1.2× 290 1.3× 95 0.8× 108 0.9× 227 2.0× 64 1.0k
George M. Ling Canada 22 433 1.6× 401 1.8× 241 2.0× 170 1.4× 89 0.8× 67 1.3k
H. Parvez France 19 318 1.2× 286 1.3× 61 0.5× 208 1.7× 95 0.8× 86 1.3k
Laura C. Berumen Mexico 15 176 0.7× 213 1.0× 52 0.4× 131 1.1× 80 0.7× 33 770
Miroslav Adžić Serbia 23 223 0.8× 382 1.7× 59 0.5× 165 1.4× 120 1.0× 66 1.4k
Norio Kokka United States 20 554 2.1× 329 1.5× 77 0.6× 164 1.3× 125 1.1× 28 1.2k

Countries citing papers authored by A. Lévy

Since Specialization
Citations

This map shows the geographic impact of A. Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lévy more than expected).

Fields of papers citing papers by A. Lévy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lévy. The network helps show where A. Lévy may publish in the future.

Co-authorship network of co-authors of A. Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lévy. A scholar is included among the top collaborators of A. Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lévy. A. Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gilat, Eran, Tamar Kadar, A. Lévy, et al.. (2005). Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: An electrographic, behavioral, and histological study in freely moving rats. Toxicology and Applied Pharmacology. 209(1). 74–85. 49 indexed citations
3.
Lévy, A., Shira Chapman, Giora Cohen, et al.. (2004). Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes. Journal of Applied Toxicology. 24(6). 501–504. 16 indexed citations
4.
Gilat, Eran, Michaël Goldman, Eli Lahat, et al.. (2002). Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig. Archives of Toxicology. 77(3). 167–172. 24 indexed citations
5.
Kadar, Tamar, Shlomit Dachir, Barbara Shukitt‐Hale, & A. Lévy. (1998). Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction. Journal of Neural Transmission. 105(8-9). 987–1004. 71 indexed citations
6.
Lévy, A., et al.. (1996). Action of steroid hormones on growth and differentiation of CNS and spinal cord organotypic cultures. Cellular and Molecular Neurobiology. 16(3). 445–450. 14 indexed citations
7.
Lévy, A., et al.. (1996). A new organotypic culture method to study the actions of steroid hormones on the nervous system. Journal of Neuroscience Research. 43(6). 719–725. 3 indexed citations
8.
Feher, Michael, Adrienne D. Cox, A. Lévy, Philip Mayne, & AF Lant. (1996). Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non‐insulin dependent diabetes. BJOG An International Journal of Obstetrics & Gynaecology. 103(3). 281–283. 17 indexed citations
9.
Shukitt‐Hale, Barbara, et al.. (1996). Morphological alterations in the hippocampus following hypobaric hypoxia. Human & Experimental Toxicology. 15(4). 312–319. 64 indexed citations
10.
Dachir, Shlomit, et al.. (1995). Nimodipine Counteracts Corticosterone-Induced Habituation Impairments. Neurobiology of Learning and Memory. 63(3). 241–245. 9 indexed citations
11.
Lévy, A., Rachel Brandeis, T. A. Treves, et al.. (1994). Transdermal Physostigmine in the Treatment of Alzheimerʼs Disease. Alzheimer Disease & Associated Disorders. 8(1). 15–21. 37 indexed citations
12.
Lévy, A., et al.. (1994). Aging, Stress, and Cognitive Functiona. Annals of the New York Academy of Sciences. 717(1). 79–88. 39 indexed citations
13.
Kadar, Tamar, et al.. (1994). Morphological hippocampal changes during normal aging and their relation to cognitive deterioration. PubMed. 44. 133–143. 30 indexed citations
14.
Fahrer, H, et al.. (1991). Diet and fatty acids: can fish substitute for fish oil?. PubMed. 9(4). 403–6. 6 indexed citations
15.
Brandeis, Rachel, Shlomit Dachir, Michal Sapir, A. Lévy, & Abraham Fisher. (1990). Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B. Pharmacology Biochemistry and Behavior. 36(1). 89–95. 64 indexed citations
16.
Fisher, Abraham, Rachel Brandeis, Zipora Pittel, et al.. (1989). (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats. Neuroscience Letters. 102(2-3). 325–331. 56 indexed citations
17.
Belmaker, Robert H., Richard P. Ebstein, Haim Dasberg, et al.. (1979). The effect of propranolol treatment in schizophrenia on CSF amine metabolites and prolactin. Psychopharmacology. 63(3). 293–296. 18 indexed citations
18.
Ngai, S. H., A. Lévy, Alfred Finck, Junichi Yano, & S. Spector. (1977). Central nervous system toxicity of hyperbaric oxygen-effects of light, norepinephrine depletion and beta-adrenergic blockade☆. Neuropharmacology. 16(10). 675–679. 8 indexed citations
19.
Kawashima, Kenji, A. Lévy, & S. Spector. (1976). Stereospecific radioimmunoassay for propranolol isomers.. Journal of Pharmacology and Experimental Therapeutics. 196(2). 517–523. 83 indexed citations
20.
Gintzler, Alan R., A. Lévy, & S. Spector. (1976). Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide, morphine-like compound in the central nervous system.. Proceedings of the National Academy of Sciences. 73(6). 2132–2136. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Perrie M. Adams Breakdown of academic impact, for papers by S.K. Kulkarni Breakdown of academic impact, for papers by Dorothy E. Woolley Breakdown of academic impact, for papers by Roberta Monterazzo Cysneiros Breakdown of academic impact, for papers by Mario Eduardo Flores-Soto Breakdown of academic impact, for papers by George M. Ling Breakdown of academic impact, for papers by H. Parvez Breakdown of academic impact, for papers by Laura C. Berumen Breakdown of academic impact, for papers by Miroslav Adžić Breakdown of academic impact, for papers by Norio Kokka
Rankless by CCL
2026